Resveratrol and its derivates improve inflammatory bowel disease by targeting gut microbiota and inflammatory signaling pathways
Inflammatory bowel disease (IBD) is a chronic inflammatory lesion of the intestine, mainly manifested by infiltration of intestinal inflammatory cells and imbalance of gut microbiota. Conventional treatments for IBD include antibiotics, immunosuppressive agents, 5-aminosalicylic acid, steroids and s...
Saved in:
Main Authors: | Ming Li, Ping Li, Rongxue Tang, Hui Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Tsinghua University Press
2022-01-01
|
Series: | Food Science and Human Wellness |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213453021000690 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic application and potential mechanism of plant-derived extracellular vesicles in inflammatory bowel disease
by: Jinling Li, et al.
Published: (2025-02-01) -
Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease
by: Yu-Chieh Tsai, et al.
Published: (2025-02-01) -
Antioxidant and anti-inflammatory roles of tea polyphenols in inflammatory bowel diseases
by: Van-Long Truong, et al.
Published: (2022-05-01) -
Gut Microbiota as Emerging Players in the Development of Alcohol-Related Liver Disease
by: Wei Li, et al.
Published: (2024-12-01) -
The protective effect of carnosic acid on dextran sulfate sodium-induced colitis based on metabolomics and gut microbiota analysis
by: Changhui Du, et al.
Published: (2023-07-01)